TrialAnnals of the rheumatic diseases2023
Efficacy and safety of tofacitinib in patients with polymyalgia rheumatica: a phase 2 study.
Le Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papertrialcites it